Riskpilot← Back to searchSign inGet full accessAB Salut
ABActiveOrg 5592008337Uttervägen 7 B 202General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2025
SEK 850K
-45% vs 2024
EBITDA margin
20.4%
-80% vs 2024
Equity ratio
87.5%
Financial strength
Net profit 2025
SEK 130K
-80% vs 2024
| Revenue | SEK 850K | -45% |
| EBITDA | SEK 174K | -80% |
| Net profit | SEK 130K | -80% |
| Total assets | SEK 2,6M | -9% |
| Equity | SEK 2,3M | -3% |
| Employees | 0 | — |
Legal name
AB Salut
Org number
5592008337
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinska konsultverksamheter, medicinska konsultationer, medicinska bemanningsverksamheter, medicinska utbildningar, läkemedelsprövning, medicinska förskningar, medicinsk teknologi och användning, privat läkarverksamhet, privat läkarmottagning. Vi skall bedriva konsultverksamhet inom sjukvård, läkarpraktik, förebyggande hälsovård samt utbildning, handledning, utveckling inom vården.
Address
Uttervägen 7 B 202
Email
vlku@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 740 | 1 312 | 1 327 | 1 533 | 850 |
| Staff expenses | — | — | — | — | −605 |
| EBITDA | 581 | 1 132 | 962 | 853 | 174 |
| Depreciation & amort. | −3 | −15 | −21 | −34 | −9 |
| EBIT | 578 | 1 117 | 941 | 819 | 165 |
| Net financials | −5 | — | 13 | — | 1 |
| Profit before tax | 573 | 1 118 | 954 | 819 | 166 |
| Tax | −118 | −231 | −197 | −171 | −36 |
| Net profit | 455 | 887 | 757 | 648 | 130 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 166 | 1 828 | 2 338 | 2 874 | 2 613 |
| Equity | 822 | 1 358 | 1 732 | 2 366 | 2 286 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 345 | 470 | 606 | 509 | 327 |
| Total debt | 345 | 470 | 606 | 509 | 327 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20212025
Equity ratio
87.5%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
5.7%
This company
18.4%
Market median
-69% vs market
20212025
Net profit margin
15.3%
This company
8.1%
Market median
+89% vs market
20212025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Salut also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vladimir Nord | Board of Directors | 0 companies |
| Tatiana Mordashova | Deputy Board Member | 0 companies |
| Olga Alexandra Stenbom | Deputy Board Member | 0 companies |